Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., disposed of 1,033 shares of common stock on February 6, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On February 6, 2025, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 1,033 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
- The shares were sold at a price of $1.5.
- Following the transaction, Chakraborty beneficially owns 220,239 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects a routine transaction for tax purposes, with no indication of positive or negative implications for the company's performance.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction related to tax obligations. Such filings are common and provide transparency into executive stock transactions.
Stakeholder Impact
- The transaction has minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of transaction: Tirtha Chakraborty disposed of 1,033 shares of common stock. |
| 02/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.